Azarab Company released its unaudited report for the FY2014. With its 1,000 IRR bn capital, this company recognized 310 IRR EPS which shows a 75% increase compared to the last year. Its sales and income of service delivery ratio went up by 20%; its final costs of the sold goods increased by 10%; and the statistics of its gross profit demonstrated a 71% growth compared to the previous year. Although the financial costs raised by 29%, its operating profit grew by 83%. Put these all together, investors are advised to seriously take this share into consideration.
There is a high possibility of 10 to 15 percent increase in drug prices by July in Iran, The CEO of Etla Alborz Investment Co., a pharmaceutical holding, mentioned in an interview. Although the percentage change could be different for various medicines, none of the pharmaceutical companies considered this growth in their FY2015 forecasted EPS. He also added that there are 35 active pharmaceutical companies listed in TSE and IFB with over 93 thousand IRR total assets. Pharmaceutical sector is ranked 11 among other industries in Iranian capital market by having2.5 percent of the total market cap. It’s noteworthy that the sector has a stable 10 to 15 percent profitably growth rate in the last 10 previous years.
Persian Gulf Petrochemical Industry Holding released its first audited budget for the fiscal year ending June 20, 2016 with 1839 EPS which was 12% less than the previous year. This company estimated the next year’s return ratio to be 14% less than the current year’s as 42,191,303 IRR. However, it forecasted the return resulting from investment sales to be 17% more than the current year’s as 3,750,000, relying on the return gained from selling Fajr Petrochemical Company’s shares. As a conclusion, its total income and operating profit in the FY2016 have been estimated to be 45,941,303 IRR and 45,589,666 IRR respectively which both reveal a 12% decrease compared to the last year.
With its 600,000,000,000 IRR capital, Shahid Ghandi Corporation Complex, a communication cables producer in Iran, released its audited financial statement ending March 2014 which realized 225 loss per share. It is so while this amount was 187 loss per share in the previous year with 300,000,000,000 IRR. This shows a 3% drop in the company’s gross profit and its operating profit was also 15% less than the last year’s. Although the products’ final cost decreased by 3%, it was counteracted by the 27% growth of its financial costs.
Isfahan Steel Co. spent a tough year. Despite the good production, the company could not cover its forecasted budget due to heavy recession in metals and steel market. The company had forecasted 500 IRR EPS for FY2014 which adjusted negatively to 65 IRR based on 9 months period performance. However, the company recognized 163 IRR EPS at the end of FY2014. Based on company’s reports, the company is suffering from the low demand in domestic markets but the cash export sales to countries such as Iraq, Oman, and Afghanistan reached more than 160 thousand tons in 2015. The company has predicted 85 IRR EPS for FY2015 and any boom in development and construction projects may double this number.
Iran Khodro’s surprise for shareholders
Iran khodro Company recognized 481 IRR earning per share in FY2014. This company, with almost $ 3.6B capital, has posted its unaudited performance report for FY2014 ended on 20th March. This is while Iran Khodro had recognized 96 IRR loss per share in FY2013, with $ 2.8 B capital. Iran Khodro ‘s net sales ,being $1.69 B in FY2013, surged 17 percent in FY2014.Also, Cost of goods went up by 14 percent in financial year 2014 and gross profit, with 22 percent rise , reached $659000.This company also experienced 29 percent increase in expenditures sum and operational profit, with 20 percent growth, reached $553 M.
Good Reopening for a pharmaceutical symbol
Darou Pakhsh Pharmaceutical Mfg. Company, whose ticker was halted in the stock exchange market due to its annual general assembly for FY2014 at 4899 IRR, was reopened after this company divided 650 IRR cash in its assembly. What was interesting about the reopening session for this pharmaceutical symbol was its 14 percent rise in price against the expected theoretical price, calculated at 4249 IRR, as it was transacted at 4850 IRR and continued to be positively traded at 5092 IRR and even experience buying queue with P/E rate of 4.32.
Whereas three months have passed from the Persian New Year and no act has set the feed price of the petrochemical complexes, non-official news agencies are implying a disagreement between the Ministry of Petroleum and the National Petrochemical Company on the feed price. The last act regulating the feed price is the budget act in 2014 and no act has been approved determining the feed price in the current year. Apparently, there are severe discrepancies between the Ministry of Petroleum and the National Petrochemical Company on the feed’s final prices. In fact, after the increase of the feed price to 13 cents per cubic meters, the petrochemical complexes in question would buy gas feeds at about 3445 IRR considering the 26,500 IRR exchange currency in the last year. It is so while most of them have regarded the feed price to be 8 cents with the 28,500 IRR exchange currency which equals 22800 IRR. In other words, not only do they do their best to decrease petrochemical complexes’ feed price, but also they have considered these figures in their financial statements and believe in them.
The second fixed-income Exchange-Traded Fund (ETF), Ganjineh Ayandeh Roshan Investment Fund, will offer its 10,000-rial investment units, bearing a 26.5 percent interest, starting June 6. A minimum of 10 and a maximum of 49 million investment units can be purchased by each investor. The underwriting period will be three days and most of the units have apparently been bid for. Secondary trading of the units will start in IFB’s new financial instruments market. The $15-million investment fund will deposit 90 percent of its money in banks and invest the rest on other securities. The minimum compounded daily interest of the fund is set at 23 percent, though the fund’s managers are trying to raise it to 26.5 percent with no charge.
Yazd Alloy Steel Company recognized 523 IRR earning per share, with $ 24.8 M capital at the end of FY2014 (ending on 20th March), which shows 39 % decrease against the actual EPS gained in the same period last year ,with the new capital increase. This company, with $12.1M capital, delivered 1756 IRR actual EPS in FY2013, which equaled 856 IRR EPS with the new capital increase. The net sales, demonstrate 60 % rise in FY2014 in comparison with the fiscal year before. Also, gross profit and expenditures sum rose by 74% and 3 % respectively versus last financial year. Moreover, the operational cost experienced 85 percent increase, but financial expenses were doubled and reached $4.25 M.